PubMed HealthSearch

PubMed · 2460811

[Interferons and their effects].

Abstract

The interferon system is an integral part of the defense system of the body, mediating a large variety of biologic effects. Presently, three groups of interferons (IFN) are known: IFN alpha, IFN beta and IFN gamma. IFN alpha and IFN beta show homology on the nucleotide level of about 40-50%, and both IFNs bind to a common receptor. IFN alpha and IFN beta are produced after induction by leukocytes and fibroblasts. IFN gamma is, by definition, not only an interferon but also a lymphokine, since it is a product exclusively of lymphocytes. There is no homology on the nucleotide level between IFN gamma and IFN alpha/beta. Furthermore, the receptor of IFN gamma is different from the receptor of IFN alpha/beta. IFNs are defined by their antiviral activity directed against a large number of different viruses. The target of IFN is the cell rather than the virus itself. Through binding on the cell surface and subsequent activation of specific genes IFNs induce an antiviral state which makes cells less permissive for virus replication. The antiviral state consists of various antiviral mechanisms. Among the non-antiviral effects of IFNs are the effects on cellular components of the immune system. Thus, one has postulated a role for interferons as immunoregulatory molecules. Interferons augment the expression of MHC-genes of which IFN alpha/beta only affect the molecules of class I, whereas IFN gamma affects both the molecules of class I and class II. Moreover, all IFNs increase the activity of macrophages and NK cells. Possibly the activation of components of the immune system is in part responsible for the antitumor effects of interferon.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Giese, H Kirchner. 1988. [Interferons and their effects].. https://doi.org/10.1159/000216512

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans